CFO
JNJ icon

Callan Family Office’s Johnson & Johnson JNJ Stock Holding History

Callan Family Office’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8M Sell
64,660
-2,738
-4% -$638K 0.36% 51
2025
Q4 		$13.9M Buy
67,398
+12,878
+24% +$2.55M 0.3% 62
2025
Q3 		$10.1M Sell
54,520
-1,616
-3% -$277K 0.32% 61
2025
Q2 		$8.57M Buy
56,136
+23,772
+73% +$3.65M 0.27% 76
2025
Q1 		$5.37M Sell
32,364
-3,750
-10% -$587K 0.4% 55
2024
Q4 		$5.22M Buy
36,114
+26,331
+269% +$4.08M 0.33% 53
2024
Q3 		$1.59M Buy
9,783
+2,711
+38% +$432K 0.27% 46
2024
Q2 		$1.03M Buy
7,072
+1,640
+30% +$244K 0.2% 58
2024
Q1 		$859K Sell
5,432
-68
-1% -$10.8K 0.2% 46
2023
Q4 		$862K Buy
5,500
+270
+5% +$41.4K 0.21% 45
2023
Q3 		$815K Sell
5,230
-430
-8% -$71K 0.22% 46
2023
Q2 		$937K Sell
5,660
-249
-4% -$40.2K 0.25% 47
2023
Q1 		$916K Buy
5,909
+1,495
+34% +$241K 0.22% 65
2022
Q4 		$780K Buy
+4,414
New +$762K 0.25% 41

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Callan Family Office's JNJ Position: Q1 2026 in Review

Callan Family Office reduced its Johnson & Johnson (JNJ) stake by 4.1% in Q1 2026, selling an estimated $638K and leaving 64,660 shares worth $15.8M. The position accounts for 0.36% of the portfolio, ranked #51.

Callan Family Office first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Callan Family Office held 64,660 shares of Johnson & Johnson worth $15.8M as of Q1 2026.
  • Callan Family Office sold 2,738 Johnson & Johnson shares in Q1 2026, an estimated $638K.
  • Johnson & Johnson made up 0.36% of Callan Family Office's portfolio in Q1 2026, its #51 holding.
  • Callan Family Office first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.